<DOC>
	<DOCNO>NCT00782301</DOCNO>
	<brief_summary>Confirm safety maraviroc use component combination antiretroviral therapy HIV Hepatitis co-infected patient .</brief_summary>
	<brief_title>Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Maraviroc</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>Etravirine</mesh_term>
	<criteria>HIV1 RNA viral load ≥1000 copies/mL screen visit . Detectable HCV RNA level Hepatitis B surface antigen ( HBsAg ) positive . Previous antiretroviral treatment experience least 2 antiretroviral drug class ≥3 month . Documented resistance NNRTI well document resistance another antiretroviral agent . CCR5 tropic virus detect TrofileTM assay . Suspected document active , untreated HIV1 relate Opportunistic Infection ( OI ) condition require acute therapy time randomization ( subject stable ( &gt; 1 month ) secondary OI prophylaxis regimen eligible study ; subject primary OI prophylaxis regimen duration also eligible study ) . Prior treatment darunavir/ritonavir , raltegravir , another integrase inhibitor , etravirine , maraviroc another CCR5 inhibitor 14 day time . Subjects receive treatment chronic Hepatitis expect need initiate HCV treatment within 48 week randomization . ( Subjects previously treat Hepatitis C eligible study ) . AST and/or ALT great 5 time upper limit normal ( ACTG Grade 3 ) .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>HIV Hepatitis co-infection</keyword>
</DOC>